Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 13076

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article▸
###

1,770 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 8) (Last 30 Days: 34) (Since Published: 1770) 

Company Data

More News Results

  • 2025/04/02: ACW CMO presents Xanamem pTau poster at ADPD25 conference*
  • 2025/03/27: ACW conducts Type C meeting with FDA regarding depression*
  • 2025/03/26: Actinogen presentation to ASX small & mid-caps conference*
  • 2025/03/24: Appendix 3Ys x 5*
  • 2025/03/24: Notification of cessation of securities - ACW*
  • 2025/03/24: Notification of cessation of securities - ACW*
  • 2025/03/24: Application for quotation of securities - ACW*
  • 2025/03/14: Results of Meeting*
  • 2025/03/04: Notification of buy-back - ACW*
  • 2025/02/24: ACW HY25 results Advancing to latestage clinical development*
*refer to company website